ANTIHYPERTENSIVE TREATMENT WITH COMBINED DRUG OF LOSARTAN AND HYDROCHLOROTHIAZIDE
Aim: to evaluate efficiency and safety of the combined antihypertensive drug Lozap Plus (50 mg losartan, 12,5 mg hydrochlorothiazide) in patients with arterial hypertension (AH) of I-III grade with high and very high cardiovascular risk. Material and methods: 30 patients with AH of I-III grade (13...
Main Authors: | R. M. Linchak, K. M. Shumilova, A. D. Martinyuk, T. A. Gusaim, E. V. Semyonova, L. G. Zhirova, S. A. Boitsov |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2016-01-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/999 |
Similar Items
-
COMBINED ANTIHYPERTENSIVE THERAPY: FOCUS ON A FIXED-DOSE COMBINATION OF AN ACE INHIBITOR AND A DIURETIC
by: Z. T. Astakhova, et al.
Published: (2010-10-01) -
ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-3 DEGREE WITH FIXED COMBINATION OF ENALAPRIL OR LOSARTAN WITH HYDROCHLOROTHIAZIDE
by: A. A. Kudryavtsev, et al.
Published: (2016-01-01) -
COMPARATIVE ANALYSIS OF LOSATAN AND ENALAPRIL ANTIHYPERTENSIVE EFFICACY (ELLA TRIAL)
by: N. M. Chihladze, et al.
Published: (2016-01-01) -
DIFFERENCES IN EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY IN MEN AND WOMEN: LOSARTAN VERSUS ENALAPRIL
by: E. I. Tarlovskaya, et al.
Published: (2016-01-01) -
Possibilities of rational combination antihypertensive therapy: Results of HEMERA international clinical trial
by: I E Chazova, et al.
Published: (2013-10-01)